Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Hydromorphone Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
10/31/2017
»Therapeutic Categories: Analgesia/Addiction
Fresenius Kabi USA, LLC (Revised 06/04/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Unavailable | Next release July 2026. Check wholesalers for inventory. | Other |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Unavailable | Next release July 2026. Check wholesalers for inventory. | Other |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Unavailable | Next release June 2026. Check wholesalers for inventory. | Other |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Available | Check wholesalers for inventory | |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Unavailable | Estimated recovery: TBD | Other |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Available | Check wholesalers for inventory | |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Unavailable | Next release June 2026. Check wholesalers for inventory. | Other |
| Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Available | Check wholesalers for inventory | |
| Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Unavailable | Next release July 2026. Check wholesalers for inventory. | Other |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Unavailable | Next release June 2026. Check wholesalers for inventory. | Other |
Hikma Pharmaceuticals USA, Inc. (Reverified 05/12/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. |
Hospira, Inc., a Pfizer Company (Revised 06/09/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Limited Availability | Limited Supply Available. Next Delivery: July 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Unavailable | Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Available | ||
| Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) | Limited Availability | Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) | Unavailable | Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Available | ||
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Available | ||
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Available | ||
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Available | ||
| Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Available | ||
| Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Available |
Teva Pharmaceuticals USA, Inc. (Revised 06/02/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Available | ||
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Available | ||
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Available |